financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Foot Locker To Strong Sell From Sell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Foot Locker To Strong Sell From Sell
Mar 6, 2024 5:21 AM

08:10 AM EST, 03/06/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month price target by $3 to $18, based on 10.3x our FY 25 (Jan.) EPS estimate and in line with the company's 5-year average forward P/E multiple of 10.1x. We lower our FY 25 EPS estimate by $0.25 to $1.75 and initiate our FY 26 EPS estimate at $2.00. FL posts normalized Q4 EPS of $0.38 vs. $0.97, $0.06 above consensus estimates on revenues of $2.38B vs. $2.33B and $105M above estimates. Q4 gross margin compressed 350 bps Y/Y due to higher markdowns, while SG&A remained flat as a percentage of sales. During Q4, FL opened 29 stores and closed 113 stores. FL expects flat sales in FY 25 with non-GAAP EPS between $1.50 and $1.70. FL also plans to close 4% of its stores in the new fiscal year. We believe valuation is now extreme after shares have doubled since October and now trade at 18x the upper end of its full year guidance and well above its 5-year average forward P/E multiple. FL has not proven it can grow top or bottom line consistently in this new retail environment of direct-to-consumer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Eli Lilly And Company
Jun 11, 2024
03:25 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $990 from $940, reflecting a 51.7x multiple on our 2025 EPS estimate, above LLY's historical forward P/E average. We maintain our 2024 EPS estimate at...
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Research Alert: CFRA Initiates Coverage On Celsius Holdings, Inc. With Hold Opinion
Jun 11, 2024
01:05 PM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We set our 12-month target at $65, representing an estimated 2025 P/E of 43.3x. We initiate coverage at Hold, as we see adj-EPS growth to $1.10 in 2024 and $1.50...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024
11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Crowdstrike Holdings Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Crowdstrike Holdings Inc.
Jun 10, 2024
01:25 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares of CRWD ended the trading day on Monday up more than 7% on news that the company will be joining the S&P 500 on June 24. CRWD has been...
Copyright 2023-2026 - www.financetom.com All Rights Reserved